Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets?


Journal

Applied microbiology and biotechnology
ISSN: 1432-0614
Titre abrégé: Appl Microbiol Biotechnol
Pays: Germany
ID NLM: 8406612

Informations de publication

Date de publication:
May 2019
Historique:
received: 30 11 2018
accepted: 10 02 2019
revised: 08 02 2019
pubmed: 28 2 2019
medline: 14 8 2019
entrez: 28 2 2019
Statut: ppublish

Résumé

This review covers the current knowledge of the cytochrome P450 enzymes (CYPs) of the human pathogen Mycobacterium tuberculosis (Mtb) and their endogenous redox partners, focusing on their biological function, expression, regulation, involvement in antibiotic resistance, and suitability for exploitation as antitubercular targets. The Mtb genome encodes twenty  CYPs and nine associated redox partners required for CYP catalytic activity. Transposon insertion mutagenesis studies have established the (conditional) essentiality of several of these enzymes for in vitro growth and host infection. Biochemical characterization of a handful of Mtb CYPs has revealed that they have specific physiological functions in bacterial virulence and persistence in the host. Analysis of the transcriptional response of Mtb CYPs and redox partners to external insults and to first-line antibiotics used to treat tuberculosis showed a diverse expression landscape, suggesting for some enzymes a potential role in drug resistance. Combining the knowledge about the physiological roles and expression profiles indicates that, at least five Mtb CYPs, CYP121A1, CYP125A1, CYP139A1, CYP142A1, and CYP143A1, as well as two ferredoxins, FdxA and FdxC, can be considered promising novel therapeutic targets.

Identifiants

pubmed: 30810776
doi: 10.1007/s00253-019-09697-z
pii: 10.1007/s00253-019-09697-z
pmc: PMC6469627
doi:

Substances chimiques

Antitubercular Agents 0
Bacterial Proteins 0
Cytochrome P-450 Enzyme System 9035-51-2

Types de publication

Journal Article Review

Langues

eng

Pagination

3597-3614

Références

Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8937-42
pubmed: 10430874
Nature. 2000 Aug 17;406(6797):735-8
pubmed: 10963599
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3068-73
pubmed: 11248033
Biochem Pharmacol. 2001 Jun 15;61(12):1463-70
pubmed: 11377375
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7534-9
pubmed: 11416222
Mol Microbiol. 2002 Feb;43(3):717-31
pubmed: 11929527
J Bacteriol. 2002 Jun;184(12):3287-95
pubmed: 12029045
Eur J Biochem. 2002 Jun;269(12):3005-13
pubmed: 12071965
J Bacteriol. 2002 Jul;184(14):4025-32
pubmed: 12081975
J Inorg Biochem. 2002 Sep 20;91(4):527-41
pubmed: 12237220
Microbiology. 2002 Oct;148(Pt 10):2937-49
pubmed: 12368427
Microbiology. 2002 Oct;148(Pt 10):3129-38
pubmed: 12368446
Mol Med. 2002 Nov;8(11):714-24
pubmed: 12520088
J Inorg Biochem. 2003 Jan 1;93(1-2):92-9
pubmed: 12538057
Mol Microbiol. 2003 Apr;48(1):77-84
pubmed: 12657046
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7213-8
pubmed: 12775759
J Bacteriol. 2003 Aug;185(15):4620-5
pubmed: 12867474
J Biol Chem. 2003 Nov 7;278(45):44780-90
pubmed: 12941968
J Exp Med. 2003 Sep 1;198(5):693-704
pubmed: 12953091
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12989-94
pubmed: 14569030
Antimicrob Agents Chemother. 2004 Jan;48(1):143-50
pubmed: 14693532
Infection. 2004 Apr;32(2):109-11
pubmed: 15057575
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4602-7
pubmed: 15070764
Tuberculosis (Edinb). 2004;84(3-4):205-17
pubmed: 15207490
Tuberculosis (Edinb). 2004;84(3-4):218-27
pubmed: 15207491
Tuberculosis (Edinb). 2004;84(3-4):228-38
pubmed: 15207492
Structure. 2004 Nov;12(11):1937-45
pubmed: 15530358
Antimicrob Agents Chemother. 2005 Mar;49(3):1067-75
pubmed: 15728904
J Mol Biol. 2005 Apr 1;347(3):607-21
pubmed: 15755454
J Biol Chem. 2005 May 27;280(21):20887-93
pubmed: 15767250
Infect Immun. 2005 Apr;73(4):2533-40
pubmed: 15784600
Annu Rev Pharmacol Toxicol. 2005;45:27-49
pubmed: 15822170
Biochim Biophys Acta. 2005 Apr-May;1707(2-3):157-69
pubmed: 15863094
Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8327-32
pubmed: 15928073
Biochem Soc Trans. 2005 Aug;33(Pt 4):796-801
pubmed: 16042601
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12200-5
pubmed: 16103351
J Antimicrob Chemother. 2005 Nov;56(5):948-50
pubmed: 16157618
Arch Microbiol. 2005 Nov;184(3):152-7
pubmed: 16175359
J Antimicrob Chemother. 2006 Jan;57(1):52-60
pubmed: 16303882
J Bacteriol. 2006 Mar;188(6):2214-21
pubmed: 16513751
Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4258-63
pubmed: 16537518
Trends Microbiol. 2006 May;14(5):220-8
pubmed: 16581251
Biochemistry. 2006 Jul 11;45(27):8427-43
pubmed: 16819841
Antimicrob Agents Chemother. 2006 Aug;50(8):2836-41
pubmed: 16870781
FEMS Microbiol Lett. 2006 Aug;261(2):181-6
pubmed: 16907718
J Biol Chem. 2006 Dec 22;281(51):39437-43
pubmed: 17028183
Int J Antimicrob Agents. 2006 Dec;28(6):543-4
pubmed: 17101262
J Infect Dis. 2007 Jun 1;195(11):1634-42
pubmed: 17471433
Arch Biochem Biophys. 2007 Aug 15;464(2):228-40
pubmed: 17482138
J Biol Chem. 2007 Aug 24;282(34):24816-24
pubmed: 17553785
Biochem Biophys Res Commun. 2007 Aug 17;360(1):97-102
pubmed: 17577575
J Infect Dis. 2007 Sep 1;196(5):788-95
pubmed: 17674323
Microb Drug Resist. 2008 Mar;14(1):7-11
pubmed: 18321205
Cell Host Microbe. 2008 May 15;3(5):323-30
pubmed: 18474359
Drug Metab Rev. 2008;40(3):427-46
pubmed: 18642141
Trends Microbiol. 2008 Sep;16(9):436-41
pubmed: 18701293
Res Microbiol. 1991 May;142(4):437-43
pubmed: 1871430
Lipids. 2008 Dec;43(12):1117-25
pubmed: 18769951
J Biol Chem. 2008 Nov 28;283(48):33406-16
pubmed: 18818197
ACS Chem Biol. 2008 Oct 17;3(10):619-24
pubmed: 18928249
J Immunol. 2008 Nov 15;181(10):7166-75
pubmed: 18981138
Biochimie. 1991 Apr;73(4):411-21
pubmed: 1911941
PLoS Negl Trop Dis. 2009;3(2):e372
pubmed: 19190730
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7426-31
pubmed: 19416919
J Bacteriol. 2009 Aug;191(16):5232-9
pubmed: 19542286
Mol Microbiol. 2009 Aug;73(3):329-40
pubmed: 19602152
J Biol Chem. 2009 Sep 11;284(37):25211-9
pubmed: 19605350
Arch Biochem Biophys. 2010 Jan 1;493(1):82-95
pubmed: 19635450
J Biol Chem. 2009 Oct 16;284(42):28590-8
pubmed: 19696019
J Biol Chem. 2009 Dec 18;284(51):35534-42
pubmed: 19846551
J Biol Chem. 2009 Dec 18;284(51):35524-33
pubmed: 19846552
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20687-92
pubmed: 19933331
PLoS Negl Trop Dis. 2010 Apr 06;4(4):e651
pubmed: 20386598
J Infect Dis. 2010 Jun 1;201(11):1743-52
pubmed: 20394526
Mol Microbiol. 2010 Aug;77(3):730-42
pubmed: 20545858
J Biol Chem. 2010 Nov 19;285(47):36352-60
pubmed: 20843794
J Biol Chem. 2010 Dec 3;285(49):38270-82
pubmed: 20889498
Microb Pathog. 2011 Jan;50(1):31-8
pubmed: 21035536
Bioorg Med Chem Lett. 2011 Jan 1;21(1):332-7
pubmed: 21109436
Future Med Chem. 2010 Aug;2(8):1339-53
pubmed: 21426022
J Immunol. 2011 Nov 1;187(9):4744-53
pubmed: 21957139
PLoS Pathog. 2011 Sep;7(9):e1002251
pubmed: 21980284
Mol Microbiol. 2012 Mar;83(6):1195-209
pubmed: 22340629
Cell Host Microbe. 2012 Apr 19;11(4):352-63
pubmed: 22520463
Angew Chem Int Ed Engl. 2012 Sep 10;51(37):9311-6
pubmed: 22890978
PLoS Pathog. 2012 Sep;8(9):e1002946
pubmed: 23028335
Expert Rev Anti Infect Ther. 2012 Sep;10(9):1037-47
pubmed: 23106278
Antimicrob Agents Chemother. 2013 Mar;57(3):1352-60
pubmed: 23274672
J Biol Chem. 2013 Mar 8;288(10):6788-800
pubmed: 23306194
J Biol Chem. 2013 Jun 7;288(23):16484-94
pubmed: 23615910
J Biol Chem. 2013 Jun 14;288(24):17347-59
pubmed: 23620594
Tuberculosis (Edinb). 2013 Jul;93(4):425-31
pubmed: 23673208
ChemMedChem. 2013 Sep;8(9):1451-6
pubmed: 23788280
Nucleic Acids Res. 2013 Dec;41(22):10062-76
pubmed: 23990327
Nat Commun. 2014 Feb 26;5:3369
pubmed: 24569628
Chembiochem. 2014 Mar 3;15(4):549-55
pubmed: 24677424
J Antibiot (Tokyo). 2014 Sep;67(9):655-9
pubmed: 25095807
Mol Biol Rep. 2014 Nov;41(11):7639-44
pubmed: 25098602
Cold Spring Harb Perspect Med. 2014 Aug 07;4(10):null
pubmed: 25104772
Genome Biol. 2014;15(11):502
pubmed: 25380655
PLoS Pathog. 2015 Feb 12;11(2):e1004679
pubmed: 25675247
Infect Immun. 2015 May;83(5):1778-88
pubmed: 25690095
Immunol Rev. 2015 Mar;264(1):288-307
pubmed: 25703567
PLoS Genet. 2015 May 04;11(5):e1005190
pubmed: 25938982
Arch Biochem Biophys. 2015 Nov 1;585:64-74
pubmed: 26334717
Mol Microbiol. 2016 May;100(3):510-26
pubmed: 26800324
J Biol Chem. 2016 Apr 1;291(14):7325-33
pubmed: 26833565
J Med Chem. 2016 Apr 14;59(7):3272-302
pubmed: 27002486
Nat Microbiol. 2016 Jun 06;1(8):16078
pubmed: 27573104
Sci Rep. 2016 Sep 12;6:33099
pubmed: 27616185
ChemMedChem. 2016 Nov 7;11(21):2385-2391
pubmed: 27677638
BMC Genomics. 2016 Oct 10;17(1):791
pubmed: 27724857
MBio. 2017 Jan 17;8(1):
pubmed: 28096490
Antimicrob Agents Chemother. 2017 Jul 25;61(8):
pubmed: 28584158
PLoS Pathog. 2017 Jul 14;13(7):e1006490
pubmed: 28708888
Appl Microbiol Biotechnol. 2017 Oct;101(19):7201-7212
pubmed: 28812125
Antimicrob Agents Chemother. 2017 Nov 22;61(12):
pubmed: 28993339
Sci Rep. 2017 Oct 9;7(1):12807
pubmed: 28993692
J Inorg Biochem. 2018 Mar;180:47-53
pubmed: 29232638
J Inorg Biochem. 2018 Mar;180:235-245
pubmed: 29352597
Antimicrob Agents Chemother. 2018 Jun 26;62(7):
pubmed: 29661879
Pathog Dis. 2018 Mar 1;76(2):
pubmed: 29718271
Appl Microbiol Biotechnol. 2018 Nov;102(21):9231-9242
pubmed: 30136203
J Res Med Sci. 2018 Jul 26;23:63
pubmed: 30181745
Chem Sci. 2018 Aug 23;9(41):7948-7957
pubmed: 30542550
J Exp Med. 1994 Feb 1;179(2):769-74
pubmed: 8294885
Mol Microbiol. 1993 Mar;7(6):1024-5
pubmed: 8483414
Nature. 1998 Jun 11;393(6685):537-44
pubmed: 9634230
J Biochem. 1998 Oct;124(4):694-6
pubmed: 9756611

Auteurs

Sandra Ortega Ugalde (S)

Division of Molecular Toxicology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands. s.ortegaugalde@vu.nl.

Maikel Boot (M)

Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, CT, USA.

Jan N M Commandeur (JNM)

Division of Molecular Toxicology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.

Paul Jennings (P)

Division of Molecular Toxicology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.

Wilbert Bitter (W)

Section of Molecular Microbiology, AIMMS, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands.

J Chris Vos (JC)

Division of Molecular Toxicology, Amsterdam Institute for Molecules Medicines and Systems (AIMMS), Faculty of Sciences, Vrije Universiteit, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH